Management Team

CEO Thomas ("Kerry") McCarter joined Soluble Systems in August, 2005 as Chief Executive Officer. Mr. McCarter has a proven ability to lead growth in start-up companies and in difficult "turnaround" situations. As Managing Director/President/Regional VP of Johnson & Johnson Companies in Russia and Western Europe, Mr. McCarter restructured and introduced a number of businesses to improve both market share and profitability. As VP Marketing for Johnson & Johnson Hospital Services, he introduced industry leading marketing programs and expanded J&J participation in alternative healthcare markets. Currently, he is a member of the Board of Directors of MedSci Technologies; a urology focused medical device company. Prior to his 20 years with J&J, Mr. McCarter held management positions with Procter & Gamble and General Electric in marketing, manufacturing, and human resources and wrote for FORBES Magazine. He holds a BA in Economics from the Maxwell School of Syracuse University and a Masters in Business Administration (with Distinction) from Harvard Business School.

Stephen is the newest member of the Soluble Systems management team. He is a highly experienced executive who has, over the past 20 years, successfully led global, country and multi-cultural teams. Stephen has held a number of management positions with Johnson & Johnson, Smith & Nephew, Zimmer and ConvaTec allowing him to gain strong financial and analytical skills through experiences in sales management, global/country marketing and divestiture/acquisition of corporate entities. He joins us directly from ConvaTec where he achieved sales and revenue targets for six consecutive years as the senior sales leader in both the US and Japan. Most recently, he held the role of VP, Sales and Marketing, Continence and Critical care where he was instrumental in integrating a new company (UnoMedical) into the ConvaTec family while maintaining ConvaTec’s market leadership in bowel management. Throughout his career, Stephen has consistently proven his ability to meet budgeted revenues, manage multi-faceted corporate change and successfully launch/market products both globally and in country. Stephen led the internal transition of company activities during the spin off of Zimmer from Bristol Myers Squibb resulting in successful Day One activities as a stand-alone public entity. He has also implemented major corporate change including re-organizations and consolidation/relocation of divisional headquarters. Stephen also successfully developed and launched products both globally and in country within the areas of Wound Management, Critical Care and Orthopedics. Stephen received his degree, Bachelor of Business Administration from Wilfrid Laurier University (Waterloo, Ontario, Canada) in 1986.

VP of Sales and Marketing Randy Rutherford joined Soluble Systems in January 2006 as Director of Sales and Marketing. Mr. Rutherford has worked in the wound care marketplace for over 20 years in sales and sales management. Most recently he served as VP of Business Development for Corium International, Inc. a developer and manufacturer of film products for use in Wound Care and Diagnostic applications. Mr. Rutherford began his career with Johnson and Johnson Patient Care Division in 1984 and has worked with other wound care companies such as LMI Medical, Ludlow Technical Products and Graphic Controls. He has been responsible for consistently delivering double digit sales growth as Director of several national sales forces. His particular expertise is in business-to-business contacts, matching companies and products with sales partners and developing strategies for new product introductions.

Mr. Weber has over 13 years' experience in pharmaceutical R&D and manufacturing at both branded and generic firms, most recently at Amgen Manufacturing and Pfizer Global Research.
He started his career as an analytical chemist, with research projects including food chemistry, laser spectroscopy, and separations using capillary electrophoresis and HPLC. As a QA professional, Mr. Weber brought newly formed labs into GMP compliance, led multi-site investigations for FDA Pre-Approval Inspection readiness, and developed many pilot programs for new projects. His particular areas of expertise include developing robust quality systems, auditing current systems and GMP compliance. He earned a B.S. in Chemistry from the University of Maryland in 1994.